Gingipain Inhibitors: The Alzheimer's Drug That Failed and Was Reborn
The rise, fall, and resurrection of a drug designed to block gum disease bacteria in the brain tells you everything about where Alzheimer’s research is heading.
P. Gingivalis
Gum Bacteria and Alzheimer's: The New Drug Target
A pharmaceutical company is running clinical trials on a drug that blocks toxins from gum disease bacteria found in Alzheimer’s brains — and the implications go far beyond the drug itself.